These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 17873130)

  • 41. 18F-FDOPA PET and PET/CT accurately localize pheochromocytomas.
    Imani F; Agopian VG; Auerbach MS; Walter MA; Imani F; Benz MR; Dumont RA; Lai CK; Czernin JG; Yeh MW
    J Nucl Med; 2009 Apr; 50(4):513-9. PubMed ID: 19289420
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PET studies of net blood-brain clearance of FDOPA to human brain: age-dependent decline of [18F]fluorodopamine storage capacity.
    Kumakura Y; Vernaleken I; Gründer G; Bartenstein P; Gjedde A; Cumming P
    J Cereb Blood Flow Metab; 2005 Jul; 25(7):807-19. PubMed ID: 15729292
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Loss of metabolites from monkey striatum during PET with FDOPA.
    Cumming P; Munk OL; Doudet D
    Synapse; 2001 Sep; 41(3):212-8. PubMed ID: 11391782
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo imaging of human cerebral nicotinic acetylcholine receptors with 2-18F-fluoro-A-85380 and PET.
    Gallezot JD; Bottlaender M; Grégoire MC; Roumenov D; Deverre JR; Coulon C; Ottaviani M; Dollé F; Syrota A; Valette H
    J Nucl Med; 2005 Feb; 46(2):240-7. PubMed ID: 15695782
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prospective comparison of (99m)Tc-GH SPECT/CT and (18)F-FDOPA PET/CT for detection of recurrent glioma: a pilot study.
    Karunanithi S; Bandopadhyaya GP; Sharma P; Kumar A; Singla S; Malhotra A; Gupta DK; Bal C
    Clin Nucl Med; 2014 Feb; 39(2):e121-8. PubMed ID: 23579970
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Maximum Uptake and Hypermetabolic Volume of 18F-FDOPA PET Estimate Molecular Status and Overall Survival in Low-Grade Gliomas: A PET and MRI Study.
    Tatekawa H; Yao J; Oughourlian TC; Hagiwara A; Wang C; Raymond C; Lai A; Cloughesy TF; Nghiemphu PL; Liau LM; Salamon N; Ellingson BM
    Clin Nucl Med; 2020 Dec; 45(12):e505-e511. PubMed ID: 33031233
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dopamine storage capacity in caudate and putamen of patients with early Parkinson's disease: correlation with asymmetry of motor symptoms.
    Kumakura Y; Gjedde A; Danielsen EH; Christensen S; Cumming P
    J Cereb Blood Flow Metab; 2006 Mar; 26(3):358-70. PubMed ID: 16079784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multi-graphical analysis of dynamic PET.
    Zhou Y; Ye W; Brasić JR; Wong DF
    Neuroimage; 2010 Feb; 49(4):2947-57. PubMed ID: 19931403
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preferred transport of O-(2-[18F]fluoroethyl)-D-tyrosine (D-FET) into the porcine brain.
    Makrides V; Bauer R; Weber W; Wester HJ; Fischer S; Hinz R; Huggel K; Opfermann T; Herzau M; Ganapathy V; Verrey F; Brust P
    Brain Res; 2007 May; 1147():25-33. PubMed ID: 17343835
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
    Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD
    J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas.
    Tripathi M; Sharma R; D'Souza M; Jaimini A; Panwar P; Varshney R; Datta A; Kumar N; Garg G; Singh D; Grover RK; Mishra AK; Mondal A
    Clin Nucl Med; 2009 Dec; 34(12):878-83. PubMed ID: 20139821
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Brain tumour imaging with PET: a comparison between [18F]fluorodopa and [11C]methionine.
    Becherer A; Karanikas G; Szabó M; Zettinig G; Asenbaum S; Marosi C; Henk C; Wunderbaldinger P; Czech T; Wadsak W; Kletter K
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1561-7. PubMed ID: 14579097
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of hypoxia and perfusion in human brain tumors using PET with 18F-fluoromisonidazole and 15O-H2O.
    Bruehlmeier M; Roelcke U; Schubiger PA; Ametamey SM
    J Nucl Med; 2004 Nov; 45(11):1851-9. PubMed ID: 15534054
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Joint factor and kinetic analysis of dynamic FDOPA PET scans of brain cancer patients.
    Dowson N; Bourgeat P; Rose S; Daglish M; Smith J; Fay M; Coulthard A; Winter C; MacFarlane D; Thomas P; Crozier S; Salvado O
    Med Image Comput Comput Assist Interv; 2010; 13(Pt 2):185-92. PubMed ID: 20879314
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies.
    Nagano-Saito A; Kato T; Arahata Y; Washimi Y; Nakamura A; Abe Y; Yamada T; Iwai K; Hatano K; Kawasumi Y; Kachi T; Dagher A; Ito K
    Neuroimage; 2004 Jun; 22(2):553-61. PubMed ID: 15193583
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A dual-tracer study of extrastriatal 6-[18F]fluoro-m-tyrosine and 6-[18F]-fluoro-L-dopa uptake in Parkinson's disease.
    Li CT; Palotti M; Holden JE; Oh J; Okonkwo O; Christian BT; Bendlin BB; Buyan-Dent L; Harding SJ; Stone CK; DeJesus OT; Nickles RJ; Gallagher CL
    Synapse; 2014 Aug; 68(8):325-31. PubMed ID: 24710997
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A tracer kinetic model for 18F-FHBG for quantitating herpes simplex virus type 1 thymidine kinase reporter gene expression in living animals using PET.
    Green LA; Nguyen K; Berenji B; Iyer M; Bauer E; Barrio JR; Namavari M; Satyamurthy N; Gambhir SS
    J Nucl Med; 2004 Sep; 45(9):1560-70. PubMed ID: 15347725
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical significance of striatal DOPA decarboxylase activity in Parkinson's disease.
    Ishikawa T; Dhawan V; Chaly T; Margouleff C; Robeson W; Dahl JR; Mandel F; Spetsieris P; Eidelberg D
    J Nucl Med; 1996 Feb; 37(2):216-22. PubMed ID: 8667047
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 5-(2-18F-fluoroethoxy)-L-tryptophan as a substrate of system L transport for tumor imaging by PET.
    Krämer SD; Mu L; Müller A; Keller C; Kuznetsova OF; Schweinsberg C; Franck D; Müller C; Ross TL; Schibli R; Ametamey SM
    J Nucl Med; 2012 Mar; 53(3):434-42. PubMed ID: 22331220
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Time profile of cerebral [18F]6-fluoro-L-DOPA metabolites in nonhuman primate: implications for the kinetics of therapeutic L-DOPA.
    Endres CJ; DeJesus OT; Uno H; Doudet DJ; Nickles JR; Holden JE
    Front Biosci; 2004 Jan; 9():505-12. PubMed ID: 14766386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.